Search results for "Stem Cell"

showing 10 items of 2354 documents

Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells

2006

AIM: To investigate and compare the hepatogenic transdifferentiation of adipose tissue-derived stem cells (ADSC) and bone marrow-derived mesenchymal stem cells (BMSC) in vitro. Transdifferentiation of BMSC into hepatic cells in vivo has been described. Adipose tissue represents an accessible source of ADSC, with similar characteristics to BMSC. METHODS: BMSCs were obtained from patients undergoing total hip arthroplasty and ADSC from human adipose tissue obtained from lipectomy. Cells were grown in medium containing 15% human serum. Cultures were serum deprived for 2 d before cultivating under similar pro-hepatogenic conditions to those of liver development using a 2-step protocol with sequ…

AdultTranscriptional ActivationPathologymedicine.medical_specialtyCellular differentiationAdipose tissueBone Marrow CellsBiologyStem cell markerCytochrome P-450 Enzyme SystemClinical ResearchAlbuminsCell Line TumormedicineCytochrome P-450 CYP3AHumansCells CulturedAgedCCAAT-Enhancer-Binding Protein-betaRegeneration (biology)Mesenchymal stem cellTransdifferentiationGastroenterologyCell DifferentiationCytochrome P-450 CYP2E1Mesenchymal Stem CellsGeneral MedicineMiddle AgedPhenotypeAdipose TissueGene Expression RegulationHepatocyte Nuclear Factor 4HepatocytesHepatic stellate cellCancer researchThy-1 AntigensStem cellWorld Journal of Gastroenterology
researchProduct

NO Reduces PMN Adhesion to Human Vascular Endothelial Cells Due to Downregulation of ICAM-1 mRNA and Surface Expression

2000

Reperfusion damage is largely due to the adherence of polymorphonuclear leukocytes to the endothelium initiated by adhesion molecule upregulation. The reduced endothelial nitric oxide release during ischemia may be involved in the upregulation of intercellular adhesion molecule 1. In this study, we tested if nitric oxide donors suppress polymorphonuclear leukocyte adherence to activated endothelial cells by inhibition of the intercellular adhesion molecule 1 surface expression. Confluent human umbilical vein endothelial cells were stimulated with tumor necrosis factor alpha (300 U/mL) after preincubation with increasing concentrations of the nitric oxide donors CAS 1609 (0.005-5 mM/L) and 3…

AdultUmbilical VeinsEndotheliumNeutrophilsIntercellular Adhesion Molecule-1Cell Culture TechniquesDown-RegulationNitric Oxide Synthase Type IINitric OxideTransfectionUmbilical veinNitric oxidechemistry.chemical_compoundmedicineCell AdhesionHumansSaphenous VeinRNA MessengerICAM-1biologyTumor Necrosis Factor-alphaMembrane ProteinsHematologyIntercellular Adhesion Molecule-1Molecular biologyEndothelial stem cellNitric oxide synthasemedicine.anatomical_structurechemistryBiochemistryGene Expression Regulationbiology.proteinTumor necrosis factor alphaEndothelium VascularNitric Oxide Synthase
researchProduct

Drosophila as a model of wound healing and tissue regeneration in vertebrates.

2011

Understanding the molecular basis of wound healing and regeneration in vertebrates is one of the main challenges in biology and medicine. This understanding will lead to medical advances allowing accelerated tissue repair after wounding, rebuilding new tissues/organs and restoring homeostasis. Drosophila has emerged as a valuable model for studying these processes because the genetic networks and cytoskeletal machinery involved in epithelial movements occurring during embryonic dorsal closure, larval imaginal disc fusion/regeneration, and epithelial repair are similar to those acting during wound healing and regeneration in vertebrates. Recent studies have also focused on the use of Drosoph…

AdultWound HealingRegeneration (biology)AnatomyBiologyRegenerative medicineModels BiologicalDorsal closureCell biologyImaginal discAdult Stem CellsModels AnimalVertebratesAnimalsHumansRegenerationDrosophilaWound healingImaginal disc fusionTissue homeostasisDevelopmental BiologyAdult stem cellDevelopmental dynamics : an official publication of the American Association of Anatomists
researchProduct

The conditioned medium from osteo-differentiating human mesenchymal stem cells affects the viability of triple negative MDA-MB231 breast cancer cells

2015

This study aimed to investigate the effect of conditioned media (CM) from osteo-differentiating and adipo-differentiating human mesenchymal stem cells (MSCs) isolated from lipoaspirates of healthy female donors on the viability of triple-negative breast cancer cells MDA-MB231. The CM of undifferentiated and differentiating MSCs were collected after 7, 14, 21 and 28 days of culture. The effects of MSC CM on cell proliferation were assessed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay after 24 h. The effects of osteo-differentiating cell CM on apoptotic promotion, cell cycle impairment, mitochondrial transmembrane potential dissipation, production of react…

Adultautophagymesenchymal stem cellsCell SurvivalBreast NeoplasmsCell Differentiationapoptosibreast cancerCell Line TumorCulture Media Conditionedconditioned mediaHumansFemaleSettore BIO/06 - Anatomia Comparata E CitologiaCells CulturedCell Proliferation
researchProduct

Congenital hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta: case report.

2005

A newborn with an unusual association of hepatic mesenchymal hamartoma and mesenchymal stem villous hyperplasia of the placenta is presented. At birth, the large hepatic mass caused severe respiratory distress necessitating early surgical intervention. This report on the association of hepatic mesenchymal hamartoma and mesenchymal stem villous hyperplasia of the placenta strongly suggests a common pathogenetic origin of the 2 lesions.

Adultcongenital hereditary and neonatal diseases and abnormalitiesPathologymedicine.medical_specialtyHepatic massHamartomaPlacentaUltrasonography PrenatalDiagnosis DifferentialMesodermPostoperative ComplicationsPregnancyPlacentamedicineEdemaHepatectomyHumansRespiratory Distress Syndrome NewbornHyperplasiaRespiratory distressbusiness.industryLiver DiseasesMesenchymal stem cellInfant NewbornGeneral MedicineHydatidiform MoleHyperplasiamedicine.diseaseJaundice Obstructivemedicine.anatomical_structureHepatic Mesenchymal Hamartomaembryonic structuresPediatrics Perinatology and Child HealthUterine NeoplasmsSurgeryFemaleChorionic VillibusinessJournal of pediatric surgery
researchProduct

Scheie syndrome: enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression.

2009

Hurler-Scheie syndrome is caused by alpha-l-iduronidase deficiency. Enzyme replacement therapy (ERT) can improve physical capacity and reduces organomegaly. However, the effect on bradytrophic connective tissue is limited. As intravenously administered enzyme cannot cross the blood-brain barrier, the therapy of choice for the more severe Hurler syndrome is haematopoietic stem cell transplantation (HCT). In the more attenuated Scheie syndrome, neurological impairment is less severe; therefore, ERT may be appropriate to treat these patients. Information on long-term outcome in Scheie patients undergoing ERT is scarce. We report a 38-year-old female Scheie patient who has been on ERT for 8 yea…

Adultcongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyMucopolysaccharidosis IMyelopathyIduronidaseSpinal cord compressionMucopolysaccharidosis IGeneticsmedicineHumansEnzyme Replacement TherapyHurler syndromeGenetics (clinical)business.industryHematopoietic Stem Cell Transplantationnutritional and metabolic diseasesBrainEnzyme replacement therapymedicine.diseaseSpinal cordSurgeryTransplantationmedicine.anatomical_structureCervical VertebraeDisease ProgressionFemaleScheie syndromebusinessSpinal Cord CompressionJournal of inherited metabolic disease
researchProduct

Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breas…

2001

The aim of this study was to determine whether the detection of CTC in the apheresis product contribute significantly to treatment failure of patients with high-risk breast carcinoma treated with high-dose chemotherapy (HDC) and stem cell transplantation (SCT). Patients were with stage II and III adenocarcinoma of the breast with > or = 10 axillary lymph nodes affected after primary surgery (> or = 10 N+) who had received HDC with SCT. We analyzed retrospectively the presence of CTC as assessed by immunocytochemistry (ICC) in the apheresis products obtained after standard adjuvant chemotherapy. We compared the clinical outcome of patients who received HDC and SCT with or without CTC-positiv…

Adultmedicine.medical_specialtyAxillary lymph nodesmedicine.medical_treatmentBreast NeoplasmsCell SeparationGastroenterologyBreast cancerRecurrenceRisk FactorsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansTreatment FailureSurvival rateRetrospective StudiesAnalysis of VarianceTransplantationChemotherapybusiness.industryHematopoietic Stem Cell TransplantationHematologyMiddle AgedPrognosismedicine.diseaseCombined Modality TherapyImmunohistochemistrySurgerySurvival RateTransplantationApheresismedicine.anatomical_structureBlood Component RemovalNeoplastic Stem CellsAdenocarcinomaFemaleBreast carcinomabusinessBone Marrow Transplantation
researchProduct

Features of Cytomegalovirus DNAemia Blips in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Implications for Optimization of Preemptive An…

2019

Cytomegalovirus (CMV) DNAemia occurs frequently in allogeneic hematopoietic stem cell transplant recipients (allo-HSCT). There is limited information about the incidence, features, and clinical impact of CMV DNAemia blips (episodes defined by an isolated positive PCR result) in this setting. In this retrospective study, 225 consecutive adult patients undergoing any modality of allo-HSCT at our center between May 2012 and July 2019 were included. Plasma CMV DNA load was monitored using a highly sensitive real-time PCR assay. In all, 187 of 225 patients had CMV DNAemia through day 365 after allo-HSCT (total number of episodes, n = 379). Eighty-three of the 187 patients had 1 or more blips (n …

Adultmedicine.medical_specialtyCongenital cytomegalovirus infectionCytomegalovirusAntiviral Agents03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansRetrospective StudiesFirst episodeTransplantationbusiness.industryIncidence (epidemiology)Antiviral therapyHematopoietic Stem Cell Transplantationvirus diseasesRetrospective cohort studyHematologyCmv dnaemiamedicine.diseaseTransplant RecipientsHighly sensitive030220 oncology & carcinogenesisCytomegalovirus InfectionsDNA ViralAllogeneic hematopoietic stem cell transplantbusiness030215 immunologyBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
researchProduct

Early detection of embryonic malformations by transvaginal and color Doppler sonography.

1994

A total of 834 women with uneventful pregnancies were followed prospectively until the 15th week of gestation by TVS to screen for early embryonic malformations. Twenty-eight embryonic anomalies were detected in this series (3.3%). The median gestational age at diagnosis was 11 (range, 8 to 15) weeks. Two neural tube defects were missed by early TVS screening. Two suspected abdominal wall defects were not confirmed by repeat mid-second trimester abdominal sonography representing 6.7% of all fetal malformations evident by 24 weeks of gestation. The sensitivity and specificity of TVS screening for fetal malformations in this series were 93.3 and 99.7%, respectively. In addition, the role of T…

Adultmedicine.medical_specialtyDuplex ultrasonographyEarly detectionGestational AgeSensitivity and SpecificityUltrasonography PrenatalCongenital AbnormalitiesAbdominal wallPregnancyPrevalencemedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesGynecologyFetusRadiological and Ultrasound Technologybusiness.industryNeural tubeGestational ageEmbryonic stem cellFetal Diseasesmedicine.anatomical_structureGestationFemalebusinessJournal of Ultrasound in Medicine
researchProduct

Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.

2006

Objective: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, is a novel cardiovascular risk factor produced by endothelial cells. ADMA levels are mainly regulated by the activity of dimethylarginine dimethylaminohydrolases (DDAH). Endothelial release of ADMA is increased in the presence of oxidized LDL cholesterol (oxLDL), whereas estrogens stimulate NO production by endothelial cells by increasing both expression and activity of NO synthase and by reducing ADMA levels. Thus, the aim of the present study was to evaluate the estradiol effects on the DDAH/ADMA/NO pathway in cultured human umbilical vein endothelial cells (HUVEC) exposed to LDL. Methods…

Adultmedicine.medical_specialtyEndotheliumPhysiologymedicine.drug_classImmunoblottingGene ExpressionBiologyArginineNitric OxideUmbilical veinNitric oxideAmidohydrolaseschemistry.chemical_compoundPhysiology (medical)Internal medicinemedicineElectrochemistryHumansRNA MessengerCells CulturedChromatography High Pressure LiquidAnalysis of VarianceEstradiolReverse Transcriptase Polymerase Chain ReactionEndothelial CellsEndothelial stem cellNitric oxide synthaseLipoproteins LDLmedicine.anatomical_structureEndocrinologychemistryCell cultureEstrogenbiology.proteinEndothelium VascularNitric Oxide SynthaseCardiology and Cardiovascular MedicineAsymmetric dimethylarginineCardiovascular research
researchProduct